Clinical trial
Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or…
NCT00063986 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00063986 |
|---|---|
| Title | Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer |
| Official title | Minimally Invasive Esophagectomy (MIE): A Multicenter Feasibility Study |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Procedure |
| Interventions | Minimally invasive esophagectomy (MIE) |
| Enrollment | 110 |
| Start date | Jun 24, 2004 |
| Primary completion | Dec 1, 2010 |
| Completion | Aug 1, 2012 |
| First posted | Jul 9, 2003 |
| Last update posted | Jun 29, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: